Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Scandinavian Medical Solutions A/S (SMSMED.CO)
Aalborg, DK
Scandinavian Medical Solutions A/S (SMS), a global entity established in 2018 and headquartered in Aalborg, Denmark, specializes in medical imaging equipment. The company provides a comprehensive array of diagnostic and therapeutic devices, encompassing CATH lab systems, CT scanners, linear accelerators, mammography units, PET/CT and SPECT/CT systems, X-ray machines, ultrasound equipment, MRI scanners, GAMMA/SPECT systems, C-arms, mobile X-ray units, R/F systems, and DEXA scanners, among others. Furthermore, SMS supplies critical spare parts for specific equipment types including CT, MRI, CATH lab, X-ray, mammography, PET/CT, and C-arm systems. Beyond sales, their offerings extend to equipment rental and technical support services. SMS serves a broad clientele, including hospitals, various medical clinics, and distributors worldwide.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -2.88% | -4.59% | -17.68% | -33.66% | -39.05% | -44.56% | -75.12% | -48.08% | -48.08% | -48.08% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Devices: +11.2%+8.3% Q1'26: -10.0% (vs Q1'24)
-
EPS growth Medical - Devices: +28.5%-99.7% Q1'26: -475.0% (vs Q1'24)
-
FCF margin FCF growth · Medical - Devices: +30.9%-8.6% Q1'26: -12.3% (vs Q1'24)
-
EBIT margin Medical - Devices: +6.2%+1.0% Q1'26: -13.1% (vs Q1'24)
-
ROIC Medical - Devices: +3.3%+1.0% Q1'26: -25.4% (vs Q1'24)
-
Share dilution Medical - Devices: 0.0%+0.8% Q1'26: +1.2% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×5.78× Q1'26: -2.67× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Sep 2025 actual |
Sep 2026 1 Rev. Ana. 1 EPS Ana. |
Sep 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|
| Revenue |
245.44M
est: 228.50M (+7.4%)
|
214.90M
214.90M – 214.90M
-6.0% YoY
|
267.40M
267.40M – 267.40M
+24.4% YoY
|
| EBITDA |
10.99M
est: 24.88M (-55.8%)
|
23.40M
23.40M – 23.40M
-6.0% YoY
|
29.11M
29.11M – 29.11M
+24.4% YoY
|
| EBIT |
2.37M
est: 20.47M (-88.4%)
|
19.26M
19.26M – 19.26M
-6.0% YoY
|
23.96M
23.96M – 23.96M
+24.4% YoY
|
| Net Income |
26.0K
est: 4.43M (-99.4%)
|
-2.77M
-2.77M – -2.77M
-162.5% YoY
|
5.54M
5.54M – 5.54M
+300.0% YoY
|
| SGA |
—
est: 9.15M (-100.0%)
|
8.60M
8.60M – 8.60M
-6.0% YoY
|
10.70M
10.70M – 10.70M
+24.4% YoY
|
| EPS |
0.00
est: 0.16 (-99.4%)
|
-0.10
-0.10 – -0.10
-162.5% YoY
|
0.20
0.20 – 0.20
+300.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Edgars Indzeris | Head of Trading | — | male |
| Jakob Ulbaek Andersen | Head of Rental | — | — |
| Jens Hvid Paulsen | Chief Executive Officer, Member of Executive Board & Partner | — | male |
| Jens Krohn | Founder, Chief Executive Officer of US & Member of Executive Board | — | male |
| Jesper Trude | Head of Parts & Service Americas | — | — |
| Kamilla Malmaek | Chief Legal & Administrations Officer and Member of Executive Board | — | — |
| Karin Svangren | Controller | — | — |
| Morten Rosenquist | Head of Finance | — | — |
| Troels Anker Vad | Head of Aftersales | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SMSMED.CO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
